84 reports of this reaction
2.9% of all BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B reports
#2 most reported adverse reaction
DIARRHOEA is the #2 most commonly reported adverse reaction for BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B, manufactured by H E B. There are 84 FDA adverse event reports linking BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B to DIARRHOEA. This represents approximately 2.9% of all 2,903 adverse event reports for this drug.
Patients taking BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is a less commonly reported adverse event for BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B, but still significant enough to appear in the safety profile.
In addition to diarrhoea, the following adverse reactions have been reported for BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 84 FDA reports for BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 2.9% of all adverse event reports for BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.